Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Vomiting 31 Nausea 27 Neoplasms 14 Lymphoma, Non-Hodgkin 8 Leukemia, Myeloid, Acute 7 Multiple Myeloma 6 Breast Neoplasms 6 Lymphoma, Large B-Cell, Diffuse 5 Lymphoma 5 Burkitt Lymphoma 5 Sezary Syndrome 4 Primary Myelofibrosis 4 Precursor Cell Lymphoblastic Leukemia-Lymphoma 4 Myeloproliferative Disorders 4 Mycosis Fungoides 4 Lymphoma, T-Cell, Cutaneous 4 Lymphoma, Mantle-Cell 4 Lymphoma, Large-Cell, Immunoblastic 4 Lymphoma, Follicular 4 Lymphoma, B-Cell, Marginal Zone 4 Leukemia, Myelomonocytic, Chronic 4 Leukemia, Lymphocytic, Chronic, B-Cell 4 Leukemia, Hairy Cell 4 Hodgkin Disease 4 Uterine Cervical Neoplasms 3 Pdgfra-Associated Chronic Eosinophilic Leukemia 3 Pancreatic Neoplasms 3 Neoplasm Metastasis 3 Myelodysplastic Syndromes 3 Lymphoma, Large-Cell, Anaplastic 3

Interventions

Docetaxel 277 Prednisone 236 enzalutamide 175 Leuprolide 172 Radiotherapy 164 Abiraterone Acetate 153 Magnetic Resonance Spectroscopy 147 bicalutamide 137 Goserelin 134 Androgen Antagonists 111 Radiosurgery 101 acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide 100 apalutamide 78 abiraterone 75 gallium 68 PSMA-11 74 Specimen Handling 67 Gonadotropin-Releasing Hormone 58 darolutamide 56 Radiation 56 Triptorelin Pamoate 53 cabazitaxel 49 Zoledronic Acid 49 pembrolizumab 48 Radiotherapy, Intensity-Modulated 47 Flutamide 47 Brachytherapy 47 luprolide acetate gel depot 46 Standard of Care 45 Carboplatin 44 Estramustine 43

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Prostatic Neoplasms × Ondansetron × Clear all

NCT02441894 2017-01-24

PEGAZUS

Sanofi

Phase 4 Completed

Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡